• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

68Ga-FAPI-04在鉴别嫌色性肾细胞癌软组织和肝转移灶用于再分期中的优势

Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.

作者信息

Xie Fei, Fu Lilan, Zhou Wenlan

机构信息

From the Department of NanFang PET Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China.

出版信息

Clin Nucl Med. 2022 Dec 1;47(12):e758-e759. doi: 10.1097/RLU.0000000000004374. Epub 2022 Aug 12.

DOI:10.1097/RLU.0000000000004374
PMID:36342807
Abstract

Chromophobe renal cell carcinoma (RCC) is a rare tumor. We described findings of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT of metastatic chromophobe RCC in a 56-year-old woman. 68Ga-FAPI-04 PET/CT demonstrated that the metastatic lesions in the liver, left posterior abdominal wall, and the left waist had intense uptake of 68Ga-FAPI-04, which was higher than that of 18F-FDG on 18F-FDG PET/CT. 68Ga-FAPI-04 PET/CT also delineated the metastatic lesions more clearly than 18F-FDG PET/CT. This case highlights 68Ga-FAPI-04 PET/CT may be promising in restaging of chromophobe RCC.

摘要

嫌色性肾细胞癌（RCC）是一种罕见肿瘤。我们描述了一名56岁女性转移性嫌色性RCC的18F-FDG PET/CT和68Ga-FAPI-04 PET/CT检查结果。68Ga-FAPI-04 PET/CT显示肝脏、左后腹壁和左腰部的转移病灶对68Ga-FAPI-04摄取强烈，高于18F-FDG PET/CT上18F-FDG的摄取。68Ga-FAPI-04 PET/CT也比18F-FDG PET/CT更清晰地勾勒出转移病灶。该病例表明68Ga-FAPI-04 PET/CT在嫌色性RCC再分期方面可能很有前景。

相似文献

1
Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.68Ga-FAPI-04在鉴别嫌色性肾细胞癌软组织和肝转移灶用于再分期中的优势
Clin Nucl Med. 2022 Dec 1;47(12):e758-e759. doi: 10.1097/RLU.0000000000004374. Epub 2022 Aug 12.
2
A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma.[68Ga]Ga-成纤维细胞激活蛋白抑制剂-04 PET/CT 在肾细胞癌中的初步研究。
Br J Radiol. 2024 Mar 28;97(1156):859-867. doi: 10.1093/bjr/tqae025.
3
Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.68Ga-DOTA-FAPI-04 PET/CT 肿瘤成像：与 18F-FDG PET/CT 在 22 种不同癌症类型中的比较。
Clin Nucl Med. 2022 Apr 1;47(4):e333-e339. doi: 10.1097/RLU.0000000000004073.
4
A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.68Ga-LNC1007 与 2-18F-FDG/68Ga-FAPI-02 PET/CT 在多种癌症患者中的头对头比较。
Clin Nucl Med. 2023 Oct 1;48(10):861-868. doi: 10.1097/RLU.0000000000004820. Epub 2023 Sep 2.
5
Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.18F-FDG PET/CT 与 68Ga-FAPI-04 PET/CT 在胃腺癌分期和再分期中的比较。
Nucl Med Commun. 2022 Jan 1;43(1):64-72. doi: 10.1097/MNM.0000000000001489.
6
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases.68Ga-FAPI 与 18F-FDG PET/CT 对胰腺癌细胞肝转移的影像学比较。
Clin Nucl Med. 2021 Jul 1;46(7):589-591. doi: 10.1097/RLU.0000000000003561.
7
18F-FDG PET/CT and 68Ga-FAPI-4 PET/CT Findings of Bilateral Knee Osteoarthritis in a Patient With Uveal Malignant Melanoma.18F-FDG PET/CT 和 68Ga-FAPI-4 PET/CT 对眼黑色素瘤患者双侧膝关节骨关节炎的表现
Clin Nucl Med. 2022 Feb 1;47(2):e144-e146. doi: 10.1097/RLU.0000000000003854.
8
18F-FDG and 68GA-Prostate-Specific Membrane Antigen PET/CT Perform Better Than CT Alone in Restaging Papillary Renal Cell Carcinoma Recurrence.18F-FDG和68GA-前列腺特异性膜抗原PET/CT在复发性乳头状肾细胞癌再分期中的表现优于单纯CT。
Clin Nucl Med. 2021 Sep 1;46(9):e458-e460. doi: 10.1097/RLU.0000000000003660.
9
The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG.[68Ga]Ga-FAPI-04 PET/CT在[18F]FDG检查结果为阴性或不明确的原发灶不明患者中的额外作用。
Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1442-1452. doi: 10.1007/s00259-022-06095-y. Epub 2023 Jan 7.
10
Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.18F-FDG、68Ga-FAPI 和 68Ga-DOTATATE PET/CT 在胰腺神经内分泌肿瘤患者中的比较。
Clin Nucl Med. 2021 Sep 1;46(9):764-765. doi: 10.1097/RLU.0000000000003763.

引用本文的文献

1
Molecular imaging of renal cell carcinomas: ready for prime time.肾细胞癌的分子成像：准备好进入黄金时代。
Nat Rev Urol. 2024 Nov 14. doi: 10.1038/s41585-024-00962-z.
2
Is There a Role for FAPI PET in Urological Cancers?FAPI PET 在泌尿系统癌症中的作用如何？
Mol Diagn Ther. 2024 Nov;28(6):721-725. doi: 10.1007/s40291-024-00735-9. Epub 2024 Aug 24.
3
Diagnostic Performances of PET/CT Using Fibroblast Activation Protein Inhibitors in Patients with Primary and Metastatic Liver Tumors: A Comprehensive Literature Review.
基于成纤维细胞激活蛋白抑制剂的 PET/CT 对原发性和转移性肝脏肿瘤患者的诊断性能：一项全面的文献综述。
Int J Mol Sci. 2024 Jun 29;25(13):7197. doi: 10.3390/ijms25137197.
4
Low expression of ACOT13 predicts poor prognosis and immunotherapy outcome in ovarian cancer.ACOT13低表达预示卵巢癌预后不良及免疫治疗效果不佳。
Am J Transl Res. 2024 Apr 15;16(4):1424-1441. doi: 10.62347/OIQB4997. eCollection 2024.
5
A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma.[68Ga]Ga-成纤维细胞激活蛋白抑制剂-04 PET/CT 在肾细胞癌中的初步研究。
Br J Radiol. 2024 Mar 28;97(1156):859-867. doi: 10.1093/bjr/tqae025.
6
The role of [ Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study.镓[68Ga]Ga-FAPI-04 PET/CT 在肾细胞癌中的作用：一项初步研究。
Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):852-861. doi: 10.1007/s00259-023-06461-4. Epub 2023 Oct 7.
7
[Ga]Ga‑LNC1007 PET/CT in the evaluation of renal cell carcinoma: comparison with 2-[F]FDG/[Ga]Ga-PSMA PET/CT.[镓]镓‑LNC1007 PET/CT 在肾细胞癌评估中的应用：与 2-[F]FDG/[镓]镓-PSMA PET/CT 的比较。
Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):535-547. doi: 10.1007/s00259-023-06436-5. Epub 2023 Sep 20.